Limits...
A new dawn for the use of traditional Chinese medicine in cancer therapy.

Parekh HS, Liu G, Wei MQ - Mol. Cancer (2009)

Bottom Line: Although traditional Chinese medicine has benefitted one fifth of the world's population in treating a plethora of diseases, its acceptance as a real therapeutic option by the West is only now emerging.In light of a new wave of recognition being given to traditional Chinese medicine by health professionals and regulatory bodies in the West, an understanding of their molecular basis and highlighting potential future applications of a proven group of traditional Chinese medicine in the treatment of a variety of cancers is crucial - this is where their calling holds much hope and promise in both animal and human trials.Furthermore, the rationale for combining conventional agents and modern biotechnological approaches to the delivery of traditional Chinese medicine is an avenue set to revolutionize the future practice of cancer medicine - and this may well bring on a new dawn of therapeutic strategies where East truly meets West.

View Article: PubMed Central - HTML - PubMed

Affiliation: The University of Queensland, School of Pharmacy, Brisbane, Australia. h.parekh@pharmacy.uq.edu.au

ABSTRACT
Although traditional Chinese medicine has benefitted one fifth of the world's population in treating a plethora of diseases, its acceptance as a real therapeutic option by the West is only now emerging. In light of a new wave of recognition being given to traditional Chinese medicine by health professionals and regulatory bodies in the West, an understanding of their molecular basis and highlighting potential future applications of a proven group of traditional Chinese medicine in the treatment of a variety of cancers is crucial - this is where their calling holds much hope and promise in both animal and human trials. Furthermore, the rationale for combining conventional agents and modern biotechnological approaches to the delivery of traditional Chinese medicine is an avenue set to revolutionize the future practice of cancer medicine - and this may well bring on a new dawn of therapeutic strategies where East truly meets West.

Show MeSH

Related in: MedlinePlus

Plant (A) and root (B) of Scutellaria Baicalensis ('golden root') where root scale is shown as 1 cm.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC2664781&req=5

Figure 2: Plant (A) and root (B) of Scutellaria Baicalensis ('golden root') where root scale is shown as 1 cm.

Mentions: The root of Scutellaria Baicalensis (Figure 2), commonly referred to as 'Baikal skullcap', 'Huang qin' or the 'Golden Root', is probably one of the most widely used herbs in TCM preparations with its flavonoid-rich elements considered to impart anti-inflammatory, anti-viral, anti-bacterial and anti-neoplastic activity [17-20].


A new dawn for the use of traditional Chinese medicine in cancer therapy.

Parekh HS, Liu G, Wei MQ - Mol. Cancer (2009)

Plant (A) and root (B) of Scutellaria Baicalensis ('golden root') where root scale is shown as 1 cm.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC2664781&req=5

Figure 2: Plant (A) and root (B) of Scutellaria Baicalensis ('golden root') where root scale is shown as 1 cm.
Mentions: The root of Scutellaria Baicalensis (Figure 2), commonly referred to as 'Baikal skullcap', 'Huang qin' or the 'Golden Root', is probably one of the most widely used herbs in TCM preparations with its flavonoid-rich elements considered to impart anti-inflammatory, anti-viral, anti-bacterial and anti-neoplastic activity [17-20].

Bottom Line: Although traditional Chinese medicine has benefitted one fifth of the world's population in treating a plethora of diseases, its acceptance as a real therapeutic option by the West is only now emerging.In light of a new wave of recognition being given to traditional Chinese medicine by health professionals and regulatory bodies in the West, an understanding of their molecular basis and highlighting potential future applications of a proven group of traditional Chinese medicine in the treatment of a variety of cancers is crucial - this is where their calling holds much hope and promise in both animal and human trials.Furthermore, the rationale for combining conventional agents and modern biotechnological approaches to the delivery of traditional Chinese medicine is an avenue set to revolutionize the future practice of cancer medicine - and this may well bring on a new dawn of therapeutic strategies where East truly meets West.

View Article: PubMed Central - HTML - PubMed

Affiliation: The University of Queensland, School of Pharmacy, Brisbane, Australia. h.parekh@pharmacy.uq.edu.au

ABSTRACT
Although traditional Chinese medicine has benefitted one fifth of the world's population in treating a plethora of diseases, its acceptance as a real therapeutic option by the West is only now emerging. In light of a new wave of recognition being given to traditional Chinese medicine by health professionals and regulatory bodies in the West, an understanding of their molecular basis and highlighting potential future applications of a proven group of traditional Chinese medicine in the treatment of a variety of cancers is crucial - this is where their calling holds much hope and promise in both animal and human trials. Furthermore, the rationale for combining conventional agents and modern biotechnological approaches to the delivery of traditional Chinese medicine is an avenue set to revolutionize the future practice of cancer medicine - and this may well bring on a new dawn of therapeutic strategies where East truly meets West.

Show MeSH
Related in: MedlinePlus